Sign up for our newsletter
Ivonescimab improves OS in NSCLC
HARMONi-6 shows OS benefit vs PD-1
MFS benefit with apalutamide
PROTEUS shows improved MFS outcomes
ASCO 2026: TALAPRO-3 results
Data from ASCO 2026 show talazoparib improved rPFS
QoL stable with EV+pembro
EYNOTE-905 shows QoL stability
Seven-year benefit with lorlatinib
CROWN shows long-term lorlatinib benefit
2026 Neurología LOPD guidelines
Expert consensus statement on LOPD care
Read more medical news stories here.